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PEComa of the nasal septum
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Alessandro Franchi, MD, Florence, ItalyNo sponsorships or competing interests have been disclosed for
this article.
Neoplasms showing perivascular epithelioid cell differ-entiation (PEComas) constitute a group of tumors com-
posed of distinctive perivascular cells that coexpress mela-
nocytic and muscle markers.1 This family of tumors
includes angiomyolipoma, clear cell sugar tumor of the
lung, lymphangiomatosis, clear cell myomelanocytic tumor
of the falciform ligament/ligamentum teres, and other un-
usual clear cell tumors arising at a variety of visceral or soft
tissue sites.1-4 In recent years, there has been an increase in
the number of reported cases of PEComas, and it now
appears that these tumors may arise at any anatomic loca-
tion. We report the second case of PEComa occurring in the
nasal cavity.2
A 50-year-old woman visited our hospital complaining
of epistaxis, rhinorrhea, and unilateral nasal obstruction.
Physical examination revealed a well-demarcated exophytic
lesion attached to the anterior portion of the nasal septum by
a relatively broad base. The patient’s clinical history was
otherwise unremarkable, and there was no family history of
tuberous sclerosis. The lesion involved only the mucosa and
could be excised surgically without septal perforation. Re-
covery was uneventful, and six years after excision, the
patient is alive and well without evidence of local recur-
rence or metastatic disease.
Microscopic examination revealed a well-circumscribed
but not encapsulated subepithelial lesion composed of fas-
cicles and nests of plump epithelioid and spindled cells
separated by a rich network of thin-walled capillary-sized
vessels (Fig 1). Tumor cells presented clear to granular
lightly eosinophilic cytoplasm with small, centrally placed,
round to ovoid nuclei. There were rare mitoses and no
necrosis. The overlying respiratory epithelium did not show
any alteration.
The immunohistochemical stains showed a diffuse vi-
mentin and -smooth muscle actin positivity, whereas
desmin and HMB-45 were focally positive (Fig 2). Epithe-
lial membrane antigen, cytokeratins, CD10, CD31, CD34,
S-100 protein, melanoma-associated antigen recognized by
T cells (MART-1), estrogen receptor, and progesterone re-
ceptor immunostains were negative. Furthermore, aboutReceived December 15, 2008; revised February 9, 2009; accepted March 10,
0194-5998/$36.00 © 2009 American Academy of Otolaryngology–Head and Nec
doi:10.1016/j.otohns.2009.03.009three percent of the neoplastic cells were in cell cycle, as
estimated with the Ki-67 marker.
Ultrastructurally, neoplastic cells contained numerous
dense granules, whereas bundles of microfilaments were
recognized in the peripheral cytoplasm of few neoplastic
elements. The institutional review board of our hospital
approved this study.
DISCUSSION
PEComas have been described only rarely in the head and
neck region, and they involved the nasal cavity,2 the soft
tissues,3 and the oral mucosa.5 The differential diagnosis of
nasal PEComa includes several entities. Malignant mela-
noma can be distinguished from PEComa by the expression
of S-100 protein and the absence of actin immunoreactivity,
even if rare spindled melanomas may show limited actin
expression and S-100–negative melanomas have been de-
scribed. In such cases, perivascular accentuation of tumor
cells and strong and diffuse melanocytic marker positivity
are additional important features. Epithelioid PEComa may
be confused with metastatic clear cell renal carcinoma. The
Figure 1 The tumor consisted of a uniform population of spin-
dle and epithelioid cells mostly showing a clear cytoplasm.2009.
k Surgery Foundation. All rights reserved.
544 Otolaryngology–Head and Neck Surgery, Vol 141, No 4, October 2009expression of melanocytic markers and the lack of reactivity
for cytokeratins and CD10 are decisive for the diagnosis of
the former. Paraganglioma is characterized by a more or-
ganoid growth pattern and positivity for protein S-100,
chromogranin A, and synaptophysin. Morphologic evalua-
tion is the cardinal criterion in distinguishing PEComas
from true smooth muscle tumors because the role of immu-
nohistochemistry in such differential diagnosis is less
straightforward. PEComas show clear to lightly eosino-
philic cytoplasm and round to oval nuclei with small nucle-
oli instead of the diffuse cytoplasmic eosinophilia and the
“cigar-shaped” nuclei of the smooth muscle tumors that typ-
ically lack the delicate capillary network seen in PEComas. In
sinonasal hemangiopericytoma, neoplastic cells show am-
phophilic to eosinophilic cytoplasm and are organized in
short fascicles, often around vascular channels ranging from
capillary size to large sinusoidal spaces, thus mimicking the
histologic picture of PEComa. Both tumors are positive for
myogenic markers, but sinonasal hemangiopericytoma does
not express melanocytic markers.
Clinically, the vast majority of PEComas follow a benign
course, although a subset of these tumors behaves in a
malignant fashion. Malignant PEComas can be very aggres-
sive, with clinical behavior similar to a high-grade sarcoma.
In a recently published study, criteria for malignancy were
suggested,3 but, until more cases with long clinical fol-
low-up are evaluated in a systematic fashion, firm criteria
Figure 2 Focal immunostaining for HMB45 is present.for malignancy remain uncertain. Our patient is alive andwell without evidence of local recurrence or metastatic
disease six years after the surgical excision of the lesion,
indicating a benign clinical course.
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